{
    "id": "dbpedia_8200_1",
    "rank": 39,
    "data": {
        "url": "https://www.linkedin.com/pulse/labeling-compliance-challenges-pharmaceutical-packaging",
        "read_more_link": "",
        "language": "en",
        "title": "Labeling Compliance Challenges in Pharmaceutical Packaging",
        "top_image": "https://media.licdn.com/dms/image/v2/D5612AQHihhxk0ITlIA/article-cover_image-shrink_720_1280/article-cover_image-shrink_720_1280/0/1681296144529?e=2147483647&v=beta&t=qUQfNmLBr0lEzc2W5lCgaY_8tW2O3i_TYeMRxrycze0",
        "meta_img": "https://media.licdn.com/dms/image/v2/D5612AQHihhxk0ITlIA/article-cover_image-shrink_720_1280/article-cover_image-shrink_720_1280/0/1681296144529?e=2147483647&v=beta&t=qUQfNmLBr0lEzc2W5lCgaY_8tW2O3i_TYeMRxrycze0",
        "images": [
            "https://media.licdn.com/dms/image/v2/D5612AQHihhxk0ITlIA/article-cover_image-shrink_720_1280/article-cover_image-shrink_720_1280/0/1681296144529?e=2147483647&v=beta&t=qUQfNmLBr0lEzc2W5lCgaY_8tW2O3i_TYeMRxrycze0"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Gyan Consulting"
        ],
        "publish_date": "2023-04-12T11:52:02+00:00",
        "summary": "",
        "meta_description": "The labels on pharmaceutical products serve as a guide for end-users and should be consistent across products. However, standardizing labels can be a challenging process due to various obligations such as complying with regulations, updating labels promptly, and avoiding non-compliance risks.",
        "meta_lang": "en",
        "meta_favicon": "https://static.licdn.com/aero-v1/sc/h/al2o9zrvru7aqj8e1x2rzsrca",
        "meta_site_name": "",
        "canonical_link": "https://www.linkedin.com/pulse/labeling-compliance-challenges-pharmaceutical-packaging",
        "text": "The labels on pharmaceutical products serve as a guide for end-users and should be consistent across products. However, standardizing labels can be a challenging process due to various obligations such as complying with regulations, updating labels promptly, and avoiding non-compliance risks. Additional label information may also reveal issues that were not identified during drug manufacturing. Therefore, it is necessary to review and update existing label information to ensure compliance with regulations and quality standards and ultimately provide a solution to any identified issues.\n\nCompliance Issues\n\nNumerous pharmaceutical companies are struggling to comply with regulatory authorities, making effective marketing a top priority. Labeling is an essential component of the quality system, and the regulatory process is exceedingly intricate. As a crucial aspect, numerous assessments have revealed significant compliance concerns, such as:\n\nThere was a delay in submitting the newly updated safety norms to be included on the product labels, for example, the USPI, a summary of product characteristics (SPC), the patient information leaflet (PIL), as well as the USPI, and other local labels.\n\nMultiple variants of USPI, SPCs, and PILs are being overfilled on Marketing authorization holders' (MAH's) websites.\n\nFailure to provide or update safety information (e.g., warnings/ precautions, contraindications, ADRs, etc) for several products that may be clinically significant.\n\nAs proper variation applications are not finding their way to the regulatory authority, authorized information about the products is being lost.\n\nWhy Update Labels?\n\nIn the pharmaceutical industry, safety is of utmost importance, and it is imperative that all product labels are kept up-to-date. Failure to do so can result in costly consequences such as product recalls, penalties, and even complete withdrawal from the market. This can erode trust in a company and negatively impact public opinion of its quality standards and labeling practices.\n\nEffective communication and organization are key to maintaining alignment between global product information and regional or local label information, which can lead to timely updates and positive impacts on product quality.\n\nHealth authorities recommend that Marketing Authorization Holders (MAHs) review their labeling information on a periodic basis, at least annually, to address any priority issues. It is important for MAHs to update the necessary information in marketed product labels promptly, especially when new information comes to light that renders previously available labels outdated and potentially misleading. This can help prevent compliance issues and maintain trust in the safety and quality of pharmaceutical products.\n\nCompliance Challenges Pharma is Facing\n\nBelow are the challenges in detail and the ways in which pharmaceutical companies can tackle them.\n\nCompliance with Local and Global Regulations\n\nPharmaceutical companies must comply with local and global regulations regarding labelling. Failure to do so can result in penalties, recalls, and damage to the company's reputation. Regulations such as the FDA's Food, Drug, and Cosmetic Act (FDCA) require that all prescription drugs have accurate and complete labelling. Compliance with such regulations requires a thorough understanding of the regulations and the ability to keep up with any changes.\n\nSolution\n\nPharmaceutical companies must ensure that their labelling meets the requirements of the different countries in which they sell their products. This can be a complex task as different countries have different requirements.\n\nFor instance, in the US, the FDA includes drug interactions, warnings, and contraindications. In the EU, the European Medicines Agency (EMA) includes information on drug dosage, side effects, and storage. Therefore, pharmaceutical companies must have a clear understanding of the requirements in each country to avoid any compliance issues.\n\n2. Ensuring Accuracy and Consistency in Labelling\n\nAnother challenge for pharmaceutical companies is ensuring accuracy and consistency in labelling. Inaccurate or inconsistent can lead to confusion among consumers, potentially leading to serious health consequences. Inconsistencies in labeling can also lead to compliance issues and product recalls. For instance, if a drug label contains an incorrect dosage or an expired date, it can lead to health risks for patients.\n\nSolution\n\nTo avoid these issues, pharmaceutical companies must have a robust process in place. This process should include procedures to ensure that all labeling is accurate and consistent, including proofreading and quality checks. Automation can also help ensure consistency by providing standardized templates and reducing the risk of human error.\n\n3. Timely Updates to Labelling Information\n\nPharmaceutical companies must ensure that their labeling information is up to date with the latest safety information, warnings, and product information. Timely updates to labeling information are critical to maintaining compliance and ensuring patient safety. Failing to update information in a timely manner can lead to product recalls and loss of consumer trust.\n\nSolution\n\nPharmaceutical companies must have an effective process in place for updating labelling information. This process should include regular reviews of information and procedures for identifying and addressing any changes. This process should also include communication with regulatory agencies to ensure that any updates are compliant with regulatory requirements.\n\n4. Integration with the Supply Chain\n\nA lack of integration can lead to inconsistencies in labeling. Integration with the supply chain is critical to ensuring that all parties involved in the supply chain have access to accurate information.\n\nSolution\n\nPharmaceutical companies must have a supply chain that is integrated with their process. This integration can be achieved through the use of technology, such as blockchain. Blockchain technology can help ensure that all parties in the supply chain have access to the same information, reducing the risk of inconsistencies\n\nFuturistic Opportunities\n\nThe pharmaceutical industry must continue to address labeling compliance challenges to maintain quality, safety, and efficacy. As the industry evolves, new challenges will arise, and companies must adapt to ensure compliance. Below are some potential future challenges and opportunities related to pharmaceutical packaging.\n\nDigitalization and Smart Packaging\n\nDigitalization and smart packaging offer new opportunities for pharmaceutical companies to improve labeling compliance. Smart packaging technologies such as QR codes, RFID (radio-frequency identification), and NFC (near-field communication) can improve supply chain management and patient safety by enabling real-time tracking and monitoring of products. Digitalization and smart packaging can also enable automated labeling, reducing errors and saving time and costs.\n\nNew Regulations and Guidelines\n\nRegulatory requirements for pharmaceutical labeling are constantly evolving, and companies must adapt to comply with new regulations and guidelines. For example, the FDA recently introduced new guidelines for electronic labeling, which may require companies to make significant changes to their labeling processes. Companies must stay up-to-date with regulatory changes and implement them."
    }
}